Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong.

Take two mins to learn more

Investment Track Record

Investment Track Record

Investment Track Record

Our portfolio of companies

Our portfolio of companies

Our portfolio of companies

TaiSan

TaiSan develops advanced polymer electrolytes enabling safer, lower-cost sodium batteries for next-generation energy storage.

TaiSan

TaiSan develops advanced polymer electrolytes enabling safer, lower-cost sodium batteries for next-generation energy storage.

Floreon

Floreon manufactures durable plant-based bioplastics designed to replace fossil-fuel plastics with lower-carbon alternatives.

Floreon

Floreon manufactures durable plant-based bioplastics designed to replace fossil-fuel plastics with lower-carbon alternatives.

BiologIC Technologies

BiologIC Technologies creates digital and automated platforms to accelerate design and scalable manufacturing of biologic medicines.

BiologIC Technologies

BiologIC Technologies creates digital and automated platforms to accelerate design and scalable manufacturing of biologic medicines.

BioCaptiva

BioCaptiva develops polymer technologies that efficiently capture cell-free DNA to enable earlier disease detection and monitoring.

BioCaptiva

BioCaptiva develops polymer technologies that efficiently capture cell-free DNA to enable earlier disease detection and monitoring.

Evoralis

Evoralis engineers enzymes that depolymerize plastics and textiles into reusable chemical feedstocks for circular recycling.

Evoralis

Evoralis engineers enzymes that depolymerize plastics and textiles into reusable chemical feedstocks for circular recycling.

QV Bioelectronics

QV Bioelectronics develops implantable bioelectronic devices using electric fields to treat aggressive cancers such as glioblastoma.

QV Bioelectronics

QV Bioelectronics develops implantable bioelectronic devices using electric fields to treat aggressive cancers such as glioblastoma.

Q5D

Q5D builds robotic additive-manufacturing systems that embed wiring directly into 3D-printed electronic products.

Q5D

Q5D builds robotic additive-manufacturing systems that embed wiring directly into 3D-printed electronic products.

MarraBio

MarraBio engineers protein-based biomaterials that enhance cell growth for biomanufacturing, therapeutics, and cultivated-meat production.

MarraBio

MarraBio engineers protein-based biomaterials that enhance cell growth for biomanufacturing, therapeutics, and cultivated-meat production.

Descycle

Descycle uses green solvent chemistry to sustainably recover critical metals from industrial waste and electronic scrap.

Descycle

Descycle uses green solvent chemistry to sustainably recover critical metals from industrial waste and electronic scrap.

Qkine

Qkine produces ultra-pure growth factors and cytokines to improve reproducibility in stem cell and cell-therapy manufacturing.

Qkine

Qkine produces ultra-pure growth factors and cytokines to improve reproducibility in stem cell and cell-therapy manufacturing.

Nuformix

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing

Nuformix

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing

INFORMATION MEMORANDUM

Download Investment Brochure

We are delighted to share the latest edition of the EverQuest EIS Fund Information Memorandum.

By choosing EverQuest as your investment partner, you become integral to our aim to have a real contribution to our world.

By submitting you agree that the email provided is subject to our Privacy Policy.

Download Investment Brochure

We are delighted to share the latest edition of the EverQuest EIS Fund Information Memorandum.

By choosing EverQuest as your investment partner, you become integral to our aim to have a real contribution to our world.

By submitting you agree that the email provided is subject to our Privacy Policy.

Download Investment Brochure

We are delighted to share the latest edition of the EverQuest EIS Fund Information Memorandum.

By choosing EverQuest as your investment partner, you become integral to our aim to have a real contribution to our world.

By submitting you agree that the email provided is subject to our Privacy Policy.

Get in Touch with Our Team.

Get in Touch with Our Team.

Get in Touch with Our Team.

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP ("we", "us", "our") is an appointed representative of Enterprise Investment Partners LLP which is authorised and regulated by the Financial Conduct Authority ("FCA") under firm reference number FRN:604439 Our firm reference number is FRN: 1018153.

This website contains financial promotions that have been approved by Enterprise Investment Partners LLP for the purposes of section 21 of the Financial Services and Markets Act 2000. The information on this website is directed only at persons in the United Kingdom who are:

- Professional clients or eligible counterparties as defined by the FCA; or

- Certified high net worth individuals, self-certified sophisticated investors, or other persons to whom financial promotions may lawfully be made under the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.


This website and any materials or information contained herein do not constitute an offer to the public or a financial promotion to retail clients unless they meet the criteria above, nor does it constitute a Direct Offer Financial Promotion. Applications for investment may only be made on the basis of the relevant documentation, copies of which are available on request. No reliance is to be placed on the information contained in this website in making such an application.

Investments of the kind referred to in this website are high-risk and are not suitable for all investors. Such investments may be illiquid, volatile, and carry a risk of total loss of capital. Past performance is not a reliable indicator of future results.

Nothing on this website should be construed as investment advice or a recommendation. If you are in any doubt about the suitability of any investment or course of action, you should consult a suitably qualified and regulated financial adviser.

This website is not intended for distribution in any jurisdiction where such distribution would be contrary to local law or regulation.

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP ("we", "us", "our") is an appointed representative of Enterprise Investment Partners LLP which is authorised and regulated by the Financial Conduct Authority ("FCA") under firm reference number FRN:604439 Our firm reference number is FRN: 1018153.

This website contains financial promotions that have been approved by Enterprise Investment Partners LLP for the purposes of section 21 of the Financial Services and Markets Act 2000. The information on this website is directed only at persons in the United Kingdom who are:

- Professional clients or eligible counterparties as defined by the FCA; or

- Certified high net worth individuals, self-certified sophisticated investors, or other persons to whom financial promotions may lawfully be made under the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.


This website and any materials or information contained herein do not constitute an offer to the public or a financial promotion to retail clients unless they meet the criteria above, nor does it constitute a Direct Offer Financial Promotion. Applications for investment may only be made on the basis of the relevant documentation, copies of which are available on request. No reliance is to be placed on the information contained in this website in making such an application.

Investments of the kind referred to in this website are high-risk and are not suitable for all investors. Such investments may be illiquid, volatile, and carry a risk of total loss of capital. Past performance is not a reliable indicator of future results.

Nothing on this website should be construed as investment advice or a recommendation. If you are in any doubt about the suitability of any investment or course of action, you should consult a suitably qualified and regulated financial adviser.

This website is not intended for distribution in any jurisdiction where such distribution would be contrary to local law or regulation.

Site design by

EverQuest Capital Partners Logo

Transforming

industry.

Creating

legacy.

Subscribe to Newsletter

By subscribing you agree that the email provided is subject to our Privacy Policy.

Copyright ©2026. EverQuest Capital Partners

EverQuest Capital Partners LLP ("we", "us", "our") is an appointed representative of Enterprise Investment Partners LLP which is authorised and regulated by the Financial Conduct Authority ("FCA") under firm reference number FRN:604439 Our firm reference number is FRN: 1018153.

This website contains financial promotions that have been approved by Enterprise Investment Partners LLP for the purposes of section 21 of the Financial Services and Markets Act 2000. The information on this website is directed only at persons in the United Kingdom who are:

- Professional clients or eligible counterparties as defined by the FCA; or

- Certified high net worth individuals, self-certified sophisticated investors, or other persons to whom financial promotions may lawfully be made under the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.


This website and any materials or information contained herein do not constitute an offer to the public or a financial promotion to retail clients unless they meet the criteria above, nor does it constitute a Direct Offer Financial Promotion. Applications for investment may only be made on the basis of the relevant documentation, copies of which are available on request. No reliance is to be placed on the information contained in this website in making such an application.

Investments of the kind referred to in this website are high-risk and are not suitable for all investors. Such investments may be illiquid, volatile, and carry a risk of total loss of capital. Past performance is not a reliable indicator of future results.

Nothing on this website should be construed as investment advice or a recommendation. If you are in any doubt about the suitability of any investment or course of action, you should consult a suitably qualified and regulated financial adviser.

This website is not intended for distribution in any jurisdiction where such distribution would be contrary to local law or regulation.

Site design by